Woodline Partners LP

Position in SVRA — Savara Inc

CIK 1784547 San Francisco, CA

Position in SVRA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$26,149,933

+$2,971,584 QoQ

Shares Held

4,245,119

0.0% QoQ

Ownership

2.07%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#14

of 181 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. SVRA ranks #49 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,002,863	$375,096,182
2	PTGX	Protagonist Therapeutics, Inc	1,414,173	$173,349,326
3	TNGX	Tango Therapeutics, Inc.	4,000,567	$125,057,724
4	BHVN	Biohaven Ltd.	7,660,280	$113,984,966
5	COGT	Cogent Biosciences, Inc.	2,603,162	$100,742,369
6	CYTK	Cytokinetics Inc	1,100,708	$93,769,314
7	RCUS	Arcus Biosciences, Inc.	3,007,798	$92,730,412
8	ROIV	Roivant Sciences Ltd.	2,500,673	$88,498,817

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,149,933	4,245,119	0.0%	Shares	Sole	2026-08-14
2026-03-31	$23,178,349	4,245,119	+0.0%	Shares	Sole	2026-05-15
2025-12-31	$25,595,179	4,244,640	+1689.3%	Shares	Sole	2026-02-17
2025-09-30	$846,878	237,221	+52.2%	Shares	Sole	2025-11-14
2025-06-30	$355,360	155,860	-38.1%	Shares	Sole	2025-08-14
2025-03-31	$697,796	251,912	-90.6%	Shares	Sole	2025-05-15
2024-12-31	$8,248,899	2,686,938	+16.6%	Shares	Sole	2025-02-14
2024-09-30	$9,774,026	2,305,195	+514.9%	Shares	Sole	2024-11-14
2020-12-31	$431,139	374,904	-36.8%	Shares	Sole	2021-02-16
2020-09-30	$647,017	593,594	+61.1%	Shares	Sole	2020-11-16
2020-06-30	$917,365	368,420	+5.6%	Shares	Sole	2020-08-14
2020-03-31	$739,765	348,946	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.